Balsamic liniment (by vishnevsky)

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT BALSAMIC LINIMENT (BY VISHNEVSKY)

Composition:

Active substances: 1 g of liniment contains 30 mg bismuth tribromophenate (xeroform), 030 mg birch tar;

Excipients: colloidal anhydrous silicon dioxide, castor oil.

Pharmaceutical form. Liniment.

Main physicochemical characteristics: homogeneous mass of light yellow to brown color, with a grayish or greenish tint, with a specific odor.

Pharmacotherapeutic group.

Antiseptics and disinfectants. ATC code D08AX.

Pharmacological properties.

Pharmacodynamics.

Vishnevsky's balsamic liniment exerts a disinfecting, anti-inflammatory, and mild irritant effect on tissue receptors due to the components contained in its formulation. The drug promotes accelerated wound healing by normalizing tissue blood supply.

Clinical characteristics.

Indications.

Abscesses, furuncles, pressure sores, lymphadenitis, lymphangitis, burns, frostbite, trophic ulcers.

Contraindications.

Hypersensitivity to phenol and its derivatives; hypersensitivity to any component of the drug.

Interaction with other medicinal products and other forms of interaction.

When used simultaneously with other topical agents on the same areas of skin, new compounds with unpredictable effects may be formed.

Special precautions for use.

Consult a physician before starting treatment.

The liniment is intended for external use only. Before applying a dressing, the wound should be cleaned of necrotic tissue, blisters should be opened, and the wound should be rinsed with an antiseptic solution.

Avoid contact of the liniment with mucous membranes. Hands should be thoroughly washed after application to prevent any residual ointment from entering the eyes, nose, or mouth. In case of contact, rinse thoroughly with large amounts of water.

Birch tar contained in the balsamic liniment may increase sensitivity to sunlight; therefore, during summer, exposure to direct sunlight should be avoided while using this preparation.

If symptoms do not begin to improve, or if the condition worsens, or any adverse reactions occur, discontinue use of the product immediately and consult a physician for further treatment.

Use during pregnancy or breastfeeding.

As the safety of using the product during pregnancy or breastfeeding has not been studied, it should be prescribed only after careful consideration of the risk-benefit ratio.

Ability to affect reaction speed while driving or operating machinery.

There is no information available regarding the effect of the medicinal product on reaction speed while driving or operating machinery.

Method of Administration and Dosage.

For adults, apply the liniment externally as directed by a physician. Apply a thin layer to affected areas of the skin 2–3 times a day, or apply a 5–6 layer gauze dressing soaked with the preparation. Fix the dressing in place and change it once every 2–3 days.

Dressings should be continued until complete cleansing of the infected skin area is achieved.

Duration of treatment course: from 6 to 20 days.

Children.

Safety and clinical efficacy of the drug in this age group have not been studied.

Overdose.

Possible manifestations of local allergic reactions (including rash, itching), requiring anti-allergic therapy.

Adverse reactions.

With prolonged use, local allergic reactions may occur (including hyperemia, itching, skin rashes, urticaria, edema), which require anti-allergic therapy. Photosensitization reactions are possible.

If any adverse reactions occur, discontinue use of the medication and consult a physician for further treatment.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

40 g in jars, 40 g in tubes, 40 g in tubes № 1.

Prescription status.

Over-the-counter.

Manufacturer.

JSC "Lubnyfarm".

Manufacturer's address and location of business activity.

16, Barvinkova St., Lubny, Poltava region, 37500, Ukraine.

INSTRUCTION

for medical use of medicinal product

BALSAMIC LINIMENT

(by Vishnevsky)

Composition:

Active ingredients: 1 g of liniment contains 30 mg of xeroform, 30 mg of birch tar;

Excipients: colloidal anhydrous silicon dioxide, castor oil.

Pharmaceutical form. Liniment.

Main physico-chemical properties: homogeneous mass ranging from light yellow to brown in color, with a grayish or greenish tint, with a specific odor.

Pharmacotherapeutic group.

Antiseptics and disinfectants. ATC code D08A X.

Pharmacological properties.

Pharmacodynamics.

Balsamic liniment by Vishnevsky exerts antiseptic, anti-inflammatory, and mild irritant effects on tissue receptors due to its constituent components. The drug promotes accelerated wound healing by normalizing tissue blood supply.

Clinical characteristics.

Indications.

Abscesses, furuncles, pressure sores, lymphadenitis, lymphangitis, burns, frostbite, trophic ulcers.

Contraindications.

Hypersensitivity to phenol and its derivatives; hypersensitivity to any component of the drug.

Interaction with other medicinal products and other forms of interaction.

When used simultaneously on the same skin areas with other topical drugs, new compounds with unpredictable effects may be formed.

Special precautions.

Prior to initiating treatment, consult a physician.

The liniment is intended for external use only. Before applying a dressing, the wound should be cleaned from necrotic tissues, blisters opened, and rinsed with an antiseptic solution.

Avoid contact of the liniment with mucous membranes. Hands should be thoroughly washed after application to prevent residual ointment from entering the eyes, nose, or mouth. In case of contact, rinse thoroughly with large amounts of water.

Birch tar, a component of the balsamic liniment, may increase sensitivity to sunlight; therefore, during summer, exposure to sunlight should be avoided during treatment.

If symptoms do not begin to improve, worsen, or any adverse effects occur, discontinue use of the drug and consult a physician for further treatment.

Use during pregnancy or breastfeeding.

As the safety of the drug during pregnancy or breastfeeding has not been studied, it should be prescribed only after careful consideration of the benefit-risk ratio.

Effect on ability to drive or operate machinery.

There is no information regarding the effect of the drug on reaction speed when driving or operating machinery.

Method of administration and dosage.

For adults, apply externally as directed by a physician. Apply 2–3 times daily as a thin layer to affected skin areas or apply a 5–6 layer gauze dressing soaked with the preparation. Secure the dressing and change every 2–3 days.

Dressings should continue until complete cleansing of the infected skin area.

Duration of treatment: 6 to 20 days.

Children.

Safety and clinical efficacy in this age group have not been established.

Overdose.

Local allergic reactions (e.g., rash, itching) may occur, requiring anti-allergic therapy.

Adverse reactions.

With prolonged use, local allergic reactions (including hyperemia, itching, skin rashes, urticaria, edema) may occur, requiring anti-allergic therapy. Photosensitization reactions are possible.

If any adverse reactions occur, discontinue use of the medication and consult a physician for further treatment.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

40 g in jars, 40 g in tubes, 40 g in tubes № 1.

Prescription status.

Over-the-counter.

Manufacturer.

JSC "Lubnyfarm".

Manufacturer's address and location of business activity.

16, Barvinkova St., Lubny, Poltava region, 37500, Ukraine.